Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ (The Korean Society Nonclinical Study)-KSNS

ÇмúÇà»ç

·Î±×ÀÎ ¾ÆÀ̵ð ±â¾ï
 
ÇмúÇà»ç¸ñ·Ï Home > ÇмúÇà»ç > ÇмúÇà»ç¸ñ·Ï
Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ 2014³â Á¦26Â÷ Workshop °³ÃÖ ¾È³» (Program ¾È³»)
ÀÛ¼ºÀÚ °ü¸®ÀÚ email http://www.nonclinical.or.kr
Date2014³â 10¿ù 16ÀÏ 13:45Hits5848
÷ºÎÆÄÀÏ ¡Ø ÇöÀç DB¿¡´Â ÆÄÀÏÁ¤º¸°¡ ÀÖÀ¸³ª, FTP »ó¿¡ ÆÄÀÏÀÌ Á¸ÀçÇÏÁö ¾Ê½À´Ï´Ù.
¡Ø ÇöÀç DB¿¡´Â ÆÄÀÏÁ¤º¸°¡ ÀÖÀ¸³ª, FTP »ó¿¡ ÆÄÀÏÀÌ Á¸ÀçÇÏÁö ¾Ê½À´Ï´Ù.
Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ 2014³â Á¦26Â÷ Workshop °³ÃÖ ¾È³»
"Non-clinical studies for Global Drug Development"

¡á Çà»ç°³¿ä

Çà»ç¸í Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ 2014³â Á¦26Â÷ Workshop
ÁÖÁ¦ Non-clinical studies for Global Drug Development
ÀϽà 2014³â 11¿ù 20(¸ñ) ~ 21ÀÏ(±Ý)
Àå¼Ò ¿ÀÅ©¹ë¸®¸®Á¶Æ® ½Å±ÔÄÁº¥¼ÇȦ (½ºÅ°¸®Á¶Æ® Ò®) (ÁÖ¼Ò : °­¿øµµ ¿øÁֽà ÁöÁ¤¸é ¿ÀÅ©¹ë¸®2±æ 58)
´Ù¿î·Îµå [ °ø¹® ] Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ Á¦25Â÷ Workshop °³ÃÖ ¾È³»
¹®ÀÇ KSNS »ç¹«±¹ : Tel. 031) 706-2995 / E-mail. ksns@nonclinical.or.kr / ´ã´çÀÚ. Áö¼º¹Ì ¼±»ý´Ô

¡á µî·Ï ¾È³»

- »çÀüµî·Ï ¾È³»
µî·Ï±â°£ - 2014³â 10¿ù 21ÀÏ (È­) 09½Ã ~ 11¿ù 14ÀÏ (±Ý) 18½Ã
µî·Ï¹æ¹ý - ¿¬±¸È¸ ȨÆäÀÌÁö (www.nonclinical.or.kr) ÇмúÇà»ç > »çÀüµî·Ï ¸Þ´º ÀÌ¿ë
- ºñȸ¿øÀº ȸ¿ø°¡ÀÔ ÈÄ, »çÀüµî·ÏÀÌ °¡´ÉÇÕ´Ï´Ù.
- µî·Ïºñ
µî·Ïºñ ±¸ºÐ »çÀüµî·Ï ÇöÀåµî·Ï
Á¤È¸¿ø 100,000 ¿ø 150,000 ¿ø
Çлýȸ¿ø 60,000 ¿ø 100,000 ¿ø
  • »çÀüµî·Ïºñ : ÀÚ·áÁý, ¼ö·áÁõ, ¼÷¹Ú(5ÀÎ/1½Ç), ½Äºñ Æ÷ÇÔ
  • ¼¼±Ý°è»ê¼­ ¹ß±Þ(ÀÔ±ÝÀÏ ±âÁØ 1ȸ ¹ß±Þ)ÀÌ ÇÊ¿äÇÒ °æ¿ì, ¿Â¶óÀÎ µî·Ï¶§ ¼¼±Ý°è»ê¼­ ¹ßÇàÇà¿©ºÎ¸¦ üũÇϰí, »ç¾÷ÀÚµî·ÏÁõ »çº»À» ¹Ýµå½Ã ÷ºÎ
  • ÇöÀåµî·Ï ¹× Çлýµî·ÏÀÇ °æ¿ì, ¼¼±Ý°è»ê¼­ ¹ß±Þ ºÒ°¡, ¿¬±¸È¸ ÀÚü ¿µ¼öÁõ ¹ß±Þ
- ¹«ÅëÀåÀÔ±Ý (°èÁÂÀÌü)
ÀԱݰèÁ - ¿ì¸®ÀºÇà 1005-101-920320 ¢ß Å¥º£½ºÆ®ÄÁ¼³ÆÃ ºñÀӻ󿬱¸È¸
ÀԱݸ¶°¨ - ~ 2014³â 11¿ù 14ÀÏ (±Ý) 18½Ã ±îÁö
  • ÀԱݽà ¹Ýµå½Ã "¼Ò¼Ó/¼º¸í" À» ±âÀÔÇϼ¼¿ä.
  • ¹«ÅëÀå ÀÔ±Ý(°èÁÂÀÌü)ÀÌü ÈÄ, »ç¹«±¹¿¡¼­ ÀÔ±ÝÀ» È®ÀÎÇÏ´Â ½Ã°£ÀÌ 1ÀÏÁ¤µµ ¼Ò¿ä µË´Ï´Ù.
  • ½Å¿ëÄ«µå °áÁ¦´Â ºÒ°¡´É ÇÕ´Ï´Ù.
  • ±âŸ µî·Ï °ü·Ã ¹®ÀÇ»çÇ×Àº Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ »ç¹«±¹À¸·Î ¹®ÀÇÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.
    TEL. 031-706-2995, E-mail ksns@nonclinical.or.kr, °íÁ¾È­

¡á ÇÁ·Î±×·¥ ¾È³» (Draft)

DAY 1 : 2014³â 11¿ù 20ÀÏ (¸ñ)
Time Program Speaker Chairman
10:30-11:00 Registration
11:00-11:10 Opening Remark ±èµ¿È¯ ȸÀå
11:10-12:00 ½Å¾à°³¹ß È帧°ú ±¹³» GLP ÇöȲ ÇÑ»ó¼· ±³¼ö
(°Ç¾ç´ë)
12:00-13:00 Lunch
13:00-13:30 Booth Exhibition & Coffee Break
Emerging Technologies in DMPK Study
13:30-14:10 Human mass balance using accelerator mass spectroscopy (AMS) ÀÌ¹Î¿ì ¿¬±¸¿ø
(³ì½ÊÀÚ)
½ÉÇöÁÖ ¹Ú»ç
(µ¿¾ÆST)
14:10-14:50 Non-CYP drug metabolism in drug development ÀÌÇý¼÷ ±³¼ö
(°¡Å縯´ë)
14:50-15:30 Benefits and purposes of modeling and simulation in drug development ½Å¼Ò¿µ ±³¼ö
(¿ø±¤´ë)
15:30-16:10 PK/PD studies using Bio-imaging ±è»óÀº ±³¼ö
(¼­¿ï´ë)
16:10-16:40 Booth Exhibition & Coffee Break
Open innovation and licensing strategy
16:40-17:20 Sanofi¡¯s strategy for open innovation and partnering Dr. Takato Noumi
(Sanofi)
ÀÌ»óÈ£ ¹Ú»ç
(´ë¿õÁ¦¾à)
17:20-18:00 ¼º°øÀû ¶óÀ̼¾½Ì ¾Æ¿ô Àü·« ¹¬Çö»ó ´ëÇ¥
(¸ÞµðÇÁ·Ð)
18:00-20:00 ¼÷¼Ò¹èÁ¤, Annual meeting, Dinner and Recreation activity

DAY 2 : 2014³â 11¿ù 21ÀÏ (±Ý)
Time Program Speaker Chairman
08:00-09:00 Breakfast
Non-clinical studies in non-rodent species
09:00-09:40 ¿µÀå·ù Áúȯ¸ðµ¨ °³¹ß ¹× ¸ðµ¨ Ȱ¿ë »ç·Ê ÀÌ»ó·¡ ¹Ú»ç
(±¹°¡¿µÀå·ù¼¾ÅÍ)
ÃÖ¿¬½Ä ±³¼ö
(Çѱ¹Æú¸®ÅØ
¹ÙÀÌ¿À´ëÇÐ)
09:40-10:20 Non-clinical development of SAL200, a novel and potent antibacterial agent Àü¼ö¿¬ ¹Ú»ç
(ÀÎÆ®·Ð¹ÙÀÌ¿À)
10:20-10:40 Booth Exhibition & Coffee Break
10:40-11:20 Nonclinical efficacy and toxicology using minipigs ¹Ú¼Ò¿¬ ¹Ú»ç
(PWG Genetics)
11:20-12:00 ´ëü½ÃÇè¹ý °¡À̵å¶óÀÎ ¼Ò°³ ¾ÈÀÏ¿µ ÁÖ¹«°ü
(½Ä¾àó)
12:00-13:00 Luncheon (luncheon symposium-KIT ±â¼ú¼³¸íȸ, 12:00-12:30)
13:00-13:30 Booth Exhibition
Challenges and Opportunities in global drug development
13:30-14:10 Development of Sivextro (Tedizolid): A new Oxazolidinone antibiotics ÃÖ¼ºÇÐ ¹Ú»ç
(µ¿¾ÆST)
°í¿ì¼® ¹Ú»ç
(ÇÑÈ­ÄɹÌÄ®)
14:10-14:50 ADC: New site-specific conjugation technology ¹Úű³ ¹Ú»ç
(·¹°íÄ͹ÙÀÌ¿À»çÀ̾ð½º)
14:50-15:30 Roles of preformulation bridging from discovery to development Á¤¼ºÈÆ ±³¼ö
(µ¿±¹´ë)
15:30-15:40 Closing Remark ±èµ¿È¯ ȸÀå

  • TBA: To be announced
  • »ó±â ÇÁ·Î±×·¥Àº ¿¬ÀÚ ¹× ±âŸ »çÁ¤À¸·Î º¯µ¿ ¼ö ÀÖ½À´Ï´Ù.
¡á ¿ÀÅ©¹ë¸®¸®Á¶Æ® ã¾Æ¿À½Ã´Â ±æ

ÁÖ¼Ò °­¿øµµ ¿øÁֽà ÁöÁ¤¸é ¿ÀÅ©¹ë¸®2±æ 58
- [³×À̹ö Áöµµ]·Î À§Ä¡ È®ÀÎ ¹× ±³Åë Âü°í :
±³ÅëÆí ¾È³» ¿ÀÅ©¹ë¸®¸®Á¶Æ® ȨÆäÀÌÁö ³» [ã¾Æ¿À½Ã´Â ±æ] ¸Þ´º Âü°í :





Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ 2014³â Á¦26Â÷ Workshop ÇùÂù ¸ðÁý
(·±Ãµ¼¼¹Ì³ª, ºÎ½º, ±¤°í)

1. ±Í»çÀÇ ¹«±ÃÇÑ ¹ßÀüÀ» ±â¿øÇÏ¿À¸ç, Ç×»ó ÀúÈñ Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸¿¡ °ü½ÉÀ» °¡Á®Áֽɿ¡ ±íÀÌ °¨»çµå¸³´Ï´Ù.

2. Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸¿¡¼­ ÁÖ°üÇÏ´Â Á¦26Â÷ WorkshopÀ» 2014³â 11¿ù 20ÀÏ(¸ñ)~11¿ù 21ÀÏ(±Ý) ¿ÀÅ©¹ë¸®¸®Á¶Æ® ½Å±Ô ÄÁº¥¼ÇȦ¿¡¼­ " Non-clinical studies for Global Drug Development "À̶õ ÁÖÁ¦·Î °³ÃÖÇϰíÀÚ ÇÕ´Ï´Ù. ¼º°øÀûÀÎ ÇмúÇà»ç °³ÃÖ¸¦ À§ÇÏ¿© ±Í ±â°üÀÇ ·±Ãµ¼¼¹Ì³ª, ºÎ½º ¹× ±¤°í ÇùÂùÀ» ¿äû µå¸®¿À´Ï Àû±ØÀûÀÎ Âü¿© ºÎŹ µå¸³´Ï´Ù. ¶ÇÇÑ, ±Í»çÀÇ °ü°èÀںе鲲¼­µµ ÇмúÇà»ç¿¡ Âü¼®ÇÏ½Ã¾î ±Í»ç¿¡ µµ¿òÀÌ µÉ human networking°ú Çмú±³·ù¸¦ ÇÒ ¼ö ÀÖµµ·Ï ÇùÁ¶ÇÏ¿© ÁÖ½Ã¸é °¨»çÇϰڽÀ´Ï´Ù.

- ´Ù À½ -

Çà»ç¸í Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ 2014³â Á¦26Â÷ Workshop
ÁÖÁ¦ Non-clinical studies for Global Drug Development
ÀϽà 2014³â 11¿ù 20(¸ñ) ~ 21ÀÏ(±Ý)
Àå¼Ò ¿ÀÅ©¹ë¸®¸®Á¶Æ® ½Å±Ô ÄÁº¥¼ÇȦ (½ºÅ°¸®Á¶Æ® Ò®) (ÁÖ¼Ò : °­¿øµµ ¿øÁֽà ÁöÁ¤¸é ¿ÀÅ©¹ë¸®2±æ 58)
ÇùÂù³»¿ë 1) ·±Ãµ¼¼¹Ì³ª(ºÎ½º/±¤°í ¹× µµ½Ã¶ôºñ¿ë Æ÷ÇÔ): \5,000,000 (VATº°µµ)
* Á¡½É½Ã°£(12:00~13:00) / ½Ä»çÀοøÀº »çÀüµî·Ï ¸¶°¨ ÈÄ Å뺸 (2013³â ¾à 140¸í)
* 20ÀÏ(¸ñ) ¹× 21ÀÏ(±Ý) 2°³ÀÇ ·±Ãµ¼¼¹Ì³ª ¸ðÁý

2) ºÎ½º(±¤°í Æ÷ÇÔ): \2,000,000 (VATº°µµ)
* ÇùÂù¾÷ü °ü°èÀÚ 2¸í¿¡ ÇÑÇÏ¿© Çмú´ëȸ Âü°¡ºñ ¹«·á
* ¼Ò¿¬È¸Àå¿¡ 2X2 ¹ÌÅÍ Å©±âÀÇ ºÎ½º ¼³Ä¡ °¡´É /ºÎ½º ´ç Å×À̺í 1°³ ¹× ÀÇÀÚ 2°³ Á¦°ø
* ºÎ½º¼³Ä¡¿Í °ü·Ã À¯ÀÇ»çÇ× ¹× Áغñ»çÇ×Àº ÃßÈÄ °øÁö

3) ±¤°í(ÀÚ·áÁý): \1,000,000 (VATº°µµ)
¸¶°¨ÀÏÀÚ 2014³â 11¿ù 07ÀÏ (±Ý)
* ·±Ãµ¼¼¹Ì³ª ¹× ºÎ½ºÀÇ °æ¿ì, ¼±Âø¼ø ¸¶°¨ (ºÎ½º¼³Ä¡ À§Ä¡´Â ¿öÅ©¼¥ ´çÀÏ Ãß÷/ÁöÁ¤)
ÀԱݰèÁ ¿ì¸®ÀºÇà 1005-101-920320 ¢ßÅ¥º£½ºÆ®ÄÁ¼³ÆÃºñÀӻ󿬱¸È¸
°ü·Ã°ø¹® Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ 2014³â Á¦26Â÷ Workshop ÇùÂù ¸ðÁý (·±Ãµ¼¼¹Ì³ª, ºÎ½º, ±¤°í)
¹®ÀÇ ÇùÂù°ú °ü·ÃÇØ ±Ã±ÝÇϽŠ»çÇ×Àº KSNS »ç¹«±¹À¸·Î ¹®ÀÇÇÏ¿© Áֽñ⠹ٶø´Ï´Ù
KSNS »ç¹«±¹ : Tel. 031) 706-2995 / E-mail. ksns@nonclinical.or.kr / ´ã´çÀÚ. °íÁ¾È­



List
°³ÀÎÁ¤º¸Ãë±Þ¹æÄ§
¢ßµå¸²¹ÙÀÌ¿À (»ç¾÷ÀÚµî·Ï¹øÈ£ : 320-88-00843, ´ëÇ¥ : ±è»ó¿ì)
Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ (The Korean Society Nonclinical Study)
(¿ì)446-982 °æ±âµµ ¿ëÀνà ±âÈﱸ Èï´öÁß¾Ó·Î 120 U-TOWER 1411È£
Tel : 031-702-9123 , Fax : 031-213-9125, E-Mail : ksns@nonclinical.or.kr
Copyright & "The Korean Society Nonclinical Study". Website development and maintenance: "Expedition". All Rights Reserved.